LAWSUITS NEWS & LEGAL INFORMATION
Search Results for
Sort by date 2,440 pages found matching data breach- ReNu with MoistureLoc: Consumers Still at Risk
Nov-1-06 San Diego, CA: Despite being recalled in April of this year, ReNu with MoistureLoc contact lens solution was still recording a two percent market share into September, indicating that the product was still available for sale in some stores long after the recall. This market data calls into question whether or not manufacturer Bausch and Lomb was agg... - Benzene Litigation Similar to Early Days of Asbestos and Tobacco
Nov-1-06 Los Angeles, CA: Legal analysts say that the recent surge of benzene lawsuits is beginning to resemble the early days of asbestos and tobacco litigation. CFO Magazine reports that company CFOs and corporate attorneys "foresee a flood tide of benzene suits, including cases that have nothing to do with occupational exposure." CFO quotes Insurance Inf... - No Excuse for marketing Ace Inhibitors to Pregnant Women
Oct-20-06 Waltham, MA In the wake of a study published in June 2006, in The New England Journal of Medicine found a higher rate of birth defects in infants born to mothers who filled prescriptions for Angiotensin-Converting Enzyme Inhibitors (ACE inhibitors), during the first trimester of pregnancy. The FDA advised women to reconsider the use of those drugs b... - Glaxo gets Hit with another Paxil Birth Defects Lawsuit
Oct-17-06 Denver, CO Two years ago, little Eric Jackson was born with persistent pulmonary hypertension, a life-threatening lung disorder in which an infant's arteries to the lungs remain constricted after birth, limiting the amount of blood flow to the lungs and oxygen in the bloodstream. Persistent pulmonary hypertension (PPHN) is associated with substantial in... - Kaiser Kidney Program still causing Problems for Patients
Oct-15-06 San Francisco, CA Kaiser Permanente is coming under more fire for its error-plagued San Francisco kidney transplant program , despite patients being transferred to other hospitals. Kaiser announced May 12 that its kidney program was being shut down. Some patients waiting to be transferred to other programs died before the transfer could occur. Kaiser... - Ortho Evra Birth Control Patch - Statistics do not Lie
Oct-13-06 Dallas, TX During one 17-month period between April 2002 and September 2003, the FDA received 9,116 adverse reaction reports on the Ortho Evra birth control patch . In stark contrast, during a 6 year period between 1997 and September 2003, the Ortho birth control pill only generated 1,237 adverse event reports and 6 time more women were using the pill... - Zyprexa Sales Show No Amount of Lawsuits Will Deter Lilly
Sep-28-06 Indianapolis, IN Scores of new lawsuits are being filed by patients who say they took Zyprexa without knowing the risks after Eli Lilly promoted the drug to doctors as a treatment for conditions other than schizophrenia and bipolar disorder that the drug is approved to treat. In June 2005, Lilly announced plans to settle roughly 8,000 claims by pati... - Kaiser Kidney Transplant Program Gets Reprieve From Medicare Officials
Sep-25-06 San Francisco, CA In August 2006, Kaiser Permanente , the nation's largest Health Maintenance Organization, agreed to pay a $2 million fine and donate $3 million to a charity group after numerous government investigations determined that the HMO caused harm, and in some cases death, to hundreds of kidney transplant patients. Two months earlier in Ju... - FDA Needs To Ban Accutane
Sep-20-06 Austin, TX: Unfortunately hundreds of parents already know that Accutane can cause some teenagers to commit suicide. But new evidence of a link between the acne drug and depression in the journal Neuropsychopharmacology , will hopefully put an end to the years of claims by Hoffman-LaRoche that its drug is not responsible for the suicides. Scien... - Johnson & Johnson Charite Spinal Disc Under Fire
Sep-7-06 Chicago, Illinois The Pulaski and Middleman law firm in Houston, Texas heads a group of law firms that represent over 350 injured Charite spinal disc recipients. The patients allege that the disc is defective, that the device was improperly marketed and that the company did not adequately warn of the disc's dangers. The Charite artificial disc was first... - Boston Scientific and Guidant Off to Texas Slaughterhouse
Sep-6-06 Corpus Christi, TX The first, but by no means the last, Guidant trial is scheduled to begin on September 18, 2006, in Neuces County District Court in Corpus Christi, Texas before Judge Jack Hunter. The two plaintiffs, Louis Motal, 63, and Bernice Hinojosa, 65, are surviving patients implanted with Guidant's Ventak Prizm 2 defibrillators in 2001. The law... - Pfizer Celebrex Lawsuits - 1500 and Counting
Sep-4-06 The first Celebrex trial, originally set for June 6, 2006, has been delayed indefinitely, reportedly to give attorneys more time to gather information. Although no new trial date has been set, legal analysts now predict that Celebrex trials will begin in early 2007. The delay was requested by a federal judge in San Francisco, where Pfizer is facing around... - Roche puts Accutane profits over Lives of Consumers
Aug-31-06 In 1985, Accutane's package insert directed at doctors first mentioned reports of depression in patients taking the acne drug, which means that more than 20 years ago, Hoffman-LaRoche at least suspected there might be a risk of depression and suicide by persons taking the drug. However, Roche's financial records show that the company is not about to let a... - Merck still fighting Vioxx lawsuits individually
Aug-30-06 Despite two major defeats, Merck, makers of the pain reliever Vioxx, plan to fight each case individually, rather than settling them all at once. It's a strange move, considering that Merck has lost some high profile cases recently. According to Paul Davies in The Wall Street Journal , some legal observers say that Merck's decision was based on the numb... - False advertising for Pantene has upset People around the World
Aug-24-06 People from around the world have been upset by false advertising claims about Pantene Pro-V shampoo. Last year, Proctor & Gamble was accused two times of falsely advertising its products in China. In the case of Pantene Pro-V, an advertising standards agency ordered the commercial be taken off the air. Additionally, the Advertising Standards Authority... - Fen-Phen May Cause Rummage Sale of Wyeth Assets - Fen-Phen Trial Resources
Aug-23-06 On August 18, 2006, Bloomberg News reported that Wyeth has faced more than 175,000 claims since fen-phen was removed from the market, and that over the past 9 years, the company has settled many claims without forcing fen-phen users to file a lawsuit. All total, the company has set aside more than $21 billion to cover legal costs and settlements since... - Merck keeps right on pushing Fosamax
Aug-11-06 New York, NY Merck's second-best selling drug, Fosamax , has been linked to jaw bone death, although sales of the drug remain steady with no decrease whatsoever. Jaw bone deth is a condition that can involve severe pain, infection, loose teeth, exposed bone, loss of function and disfigurement, according to the American Association of Oral and Maxillofa... - Natrecor: A History of Shady Practices
Aug-6-06 It's incredulous that a drug approved for very limited use could actually be given to a wide range of people. Yet this is what happened in the case of Natrecor (nesiritide), a drug approved by the FDA for emergency use only in hospitals. Somehow, Natrecor managed to evolve from emergency-only to preventative-maintenance use, despite not receiving FDA appr... - Paxil Category Warning too late for my Baby
Aug-3-06 "This is what I want to say to GlaxoSmithKline, the manufacturers of Paxil: How can you let money come before people's lives and well-being and have no conscience?" In 2001, 22-year-old Nancy Jones went to a mental health clinic to seek treatment for anxiety and depression and was prescribed Paxil. Unfortunately, Jones didn't know that she was three mont... - Eli Lilly and Co. under fire for Zyprexa
Aug-1-06 On July 24, 2006, Mississippi became the fifth state to file a lawsuit against Eli Lilly and Co. for its sales and marketing of Zyprexa (olanzapine). The lawsuit was filed in Lafayette County Circuit Court. According to a special attorney general who is handling the case, the lawsuit was filed to recover money the state of Mississippi spent purchasin...